[
    {
        "query": "\n                Analyze the provided CSV file and generate a detailed description of each row by extracting and summarizing its features in a continuous sentence. For each row:\n\n                1. Identify and list the column names and their corresponding values.\n                2. Present the features in the row in a seamless sentence structure, describing the relationship or context between them.\n                3. Provide a summary statement based on the data, capturing notable insights, patterns, or potential interpretations.\n                ",
        "response": "Here's an analysis of the provided data, formatted as requested:\n\n\n**Row 1:**\n\n1. **Column Names and Values:**  protein_id: NP_000009.1; protein_sequence: [long sequence]; mutant: A349E; mutated_sequence: [long sequence]; annotation: Pathogenic\n\n2. **Sentence Description:** The protein with ID NP_000009.1, possessing a specific amino acid sequence, undergoes a mutation at position 349, changing alanine to glutamic acid, resulting in a pathogenic variant.\n\n3. **Summary Statement:** The A349E mutation in protein NP_000009.1 is annotated as pathogenic, indicating it likely disrupts the protein's normal function.\n\n\n**Row 2:**\n\n1. **Column Names and Values:** protein_id: NP_000009.1; protein_sequence: [long sequence]; mutant: R353K; mutated_sequence: [long sequence]; annotation: Benign\n\n2. **Sentence Description:**  In protein NP_000009.1, a mutation at position 353 replaces arginine with lysine, resulting in a benign variant, according to the annotation.\n\n3. **Summary Statement:** The R353K mutation in protein NP_000009.1 is considered benign, suggesting it does not significantly affect protein function.\n\n\n**Row 3:**\n\n1. **Column Names and Values:** protein_id: NP_000009.1; protein_sequence: [long sequence]; mutant: G350V; mutated_sequence: [long sequence]; annotation: Pathogenic\n\n2. **Sentence Description:** The protein NP_000009.1 exhibits a pathogenic mutation at position 350, where glycine is substituted by valine.\n\n3. **Summary Statement:**  The G350V mutation in protein NP_000009.1 is annotated as pathogenic, implying a detrimental effect on protein function.\n\n\n**Row 4:**\n\n1. **Column Names and Values:** protein_id: NP_000009.1; protein_sequence: [long sequence]; mutant: M334V; mutated_sequence: [long sequence]; annotation: Pathogenic\n\n2. **Sentence Description:** A methionine-to-valine mutation at position 334 in protein NP_000009.1 is classified as pathogenic.\n\n3. **Summary Statement:** The M334V mutation in protein NP_000009.1 is predicted to be pathogenic, likely causing functional impairment.\n\n\n**Row 5:**\n\n1. **Column Names and Values:** protein_id: NP_000009.1; protein_sequence: [long sequence]; mutant: K358E; mutated_sequence: [long sequence]; annotation: Pathogenic\n\n2. **Sentence Description:** Protein NP_000009.1 shows a lysine to glutamic acid substitution at position 358, which is annotated as pathogenic.\n\n3. **Summary Statement:** The K358E mutation in protein NP_000009.1 is deemed pathogenic, suggesting it negatively impacts the protein's function.\n"
    }
]